Skip to search.
 TSX Down 0.60% TSX Ventures Down 1.08%

More On AEZS

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.26 Down 0.01(4.41%) Jul 6, 4:00PM EDT
Add to Portfolio
Prev Close:0.27
Open:0.27
Bid:0.26 x 1100
Ask:0.27 x 7500
1y Target Est:1.43
Beta:1.92
Next Earnings Date:N/A
Day's Range:0.25 - 0.27
52wk Range:0.25 - 1.54
Volume:5,267,901
Avg Vol (3m):3,816,290
Market Cap:24.93M
P/E (ttm):N/A
EPS (ttm):-0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AEZSDown 4.41%24.93M
CELGDown 0.59%94.24B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):310.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback